TY - JOUR
AU - Phillips, A.
AU - Jiang, Y.
AU - Walsh, D.
AU - Andrews, Nick
AU - Artama, M.
AU - Clothier, H.
AU - Cullen, L.A.
AU - Deng, Lul Lojok
AU - Escolano, S.
AU - Gentile, A.
AU - Gidding, G.
AU - Giglio, N.
AU - Junker, T.
AU - Huang, W.
AU - Janjua, N.
AU - Kwong, J.
AU - Li, J.
AU - Nasreen, S.
AU - Naus, M.
AU - Naveed, Z.
AU - Pillsbury, A.
AU - Stowe, J.
AU - Vo, T.
AU - Buttery, J.
AU - Petousis-Harris, H.
AU - Black, S.
AU - Hviid, A.
PY - 2023
DA - October
TI - Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis
JO - Vaccine
EP - 6238
VL - 41
IS - 42
DO - https://doi.org/10.1016/j.vaccine.2023.08.079
AB - BackgroundThe Global COVID Vaccine Safety (GCoVS) project was established in 2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate the rapid assessment of the safety of newly introduced vaccines. This study analyzed data from GVDN member sites on the background incidence rates of conditions designated as adverse events of special interest (AESI) for COVID-19 vaccine safety monitoring.
PB - Elsevier
UR - https://publichealthscotland.scot/id/150332
KW - Coronavirus (COVID-19)
ER